| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 1.86 | -0.09 (-4.62%) | 0.80 - 3.05 | 100.0 (Below Avg) |
Market data as of 1:47PM 05/23/13. Quotes are delayed by at least 15 min.
Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support
05/23/2013 3:22 PM ET
Hadasit Bio-Holdings CEO Letter to Shareholders
04/09/2013 9:00 AM ET
Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA
04/04/2013 9:11 AM ET